DPYSL4 Antibody Blocking Peptide

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-11055PEP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
NBP2-11055PEP
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

Synthetic

Conjugate

Unconjugated

Applications

Antibody Competition

View all DPYSL4 Proteins and Enzymes »

Product Specifications

Description

Synthetic peptide corresponding to amino acids 509-527 of human CRMP3.

NCBI Accession #NP_006417.2

Source: Synthetic

Amino Acid Sequence: PAKPGSGTQARASCSGKIS

Purity

>85%, by HPLC

Application Notes

This peptide is useful as a blocking peptide for NBP2-11055. For further blocking peptide related protocol, click here.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NBP2-11055PEP
Formulation Sodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO
Concentration 2.5 mg/ml
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -20C. Avoid freeze-thaw cycles.

Background: DPYSL4

Collapsin response mediator proteins (CRMPs) specify axon/dendrite fate and axonal growth of neurons through protein-protein interactions. Collapsing mediated response proteins (CRMPs) form homo- and hetero tetramers and facilitate neuron guidance, growth and polarity. It is abundantly expressed in brain and regulate neurite outgrowth. The CRMP family consists of 5 subtypes (CRMP1-5) and are also known as dihydroxypyrimindinase 1-5 (DRP1-5). The CRMPs promotes microtubule assembly and is required for Sema3A-mediated growth cone collapse and also plays a role in synaptic signaling through interactions with calcium channels. CRMP2 protein regulates endocytosis where two proteins MICAL-L1 and EHD1 are important regulatory proteins that control key endocytotic transport steps. CRMP2 interacts with MICAL-L1 in non-neuronal cells (1). CRMP2 interacts with tubulin dimers and kinesin and negatively regulates s dynein-based transport in neuronal cells (2). The mammalian target of rapamycin (mTOR)is an important regulator of neuronal development and function. mTOR inhibitor, rapamycin regulates neuronal polarity by suppressing the expression of Tau and CRMP2 via mTOR effector 70-kDa ribosomal protein S6 kinase (p70S6K)p70 (2). It is suggested that abnormal activation of CDK5 is associated with neurodegeneratative disorders and it disrupts mature neuronal circuitries and neurogenesis. CDK5 and other kinases hyper-phosphorylate down-stream targets of these kinases in brain such as doublecortin, nestin, and CRMP2 (2). This gene has been implicated in multiple neurological disorders, and hyperphosphorylation of the encoded protein may play a key role in the development of Alzheimer's disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. DRP4-selective antibodies were generated against peptides form unique region near C-terminus of DRP4 protein with in aa 508-527. The epitope is conserved in several other species beside human but was unique to DRP4. The DRP4 antibodies are affinity purified over immobilized antigen based affinity chromatography and fully characterized for their listed applications and cross reactivity.

Alternate Names

CRMP-3, CRMP3Collapsin response mediator protein 3, dihydropyrimidinase-like 4, dihydropyrimidinase-related protein 4, DRP-4UNC33-like phosphoprotein 4, ULIP4ULIP-4

Gene Symbol

DPYSL4

Additional DPYSL4 Products

Product Documents for DPYSL4 Antibody Blocking Peptide

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for DPYSL4 Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.